Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001513162-17-000258

Options or other derivatives

  • Chief Operating Officer acquired 250,000 shares (grant or award)
  • Chief Operating Officer returned 250,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Catelani Michael · Chief Operating Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2017-09-06 Returned to the company : show line 1 in the form Employee Stock Option −50,000 0 D
2017-09-06 Grant or award : show line 2 in the form Employee Stock Option +50,000 50,000 D
2017-09-06 Returned to the company : show line 3 in the form Employee Stock Option −200,000 0 D
2017-09-06 Grant or award : show line 4 in the form Employee Stock Option +200,000 200,000 D
Loading xslF345X03/primary_doc.xml…